Completion of a clinical trial

15 August 2019

ClinPharmDevelopment has completed a clinical study of an antiparathyroid drug calcium mimetic action.

The first bioanalogue of the original drug for the treatment of osteoporosis in Russia has received a registration certificate from the Ministry of Health.

A phase I study of an innovative drug used in the treatment of patients with a new coronavirus infection (COVID-19) has been completed. The final report has been prepared.

Subscribe to the newsletter of interesting articles and news

Comple­tion of a clinical trial

Completion of a clinical trial